Companies / Croatia
Barr's Pliva Acquisition To Boost CEE Generics
June 2006 | FDI AlertUS firm Barr Pharmaceuticals is set to acquire Croatia generic company Pliva for US$2.2bn, which will create a powerful, global pharmaceutical company that has its sights on the booming Central and Eastern European (CEE) generics market among other targets.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
